Supplement

You have full text access to this OnlineOpen article

Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation†

  1. Alexandru Eniu MD, PhD1,‡,*,
  2. Robert W. Carlson MD2,
  3. Nagi S. El Saghir MD3,
  4. Jose Bines MD4,§,
  5. Nuran Senel Bese MD5,
  6. Daniel Vorobiof MD6,
  7. Riccardo Masetti MD7,
  8. Benjamin O. Anderson MD8,
  9. on behalf of the Breast Health Global Initiative Treatment Panel

Article first published online: 3 OCT 2008

DOI: 10.1002/cncr.23843

Issue

Cancer

Cancer

Supplement: Guidelines for International Breast Health and Cancer Control–Implementation

Volume 113, Issue Supplement 8, pages 2269–2281, 15 October 2008

Additional Information

How to Cite

Eniu, A., Carlson, R. W., El Saghir, N. S., Bines, J., Bese, N. S., Vorobiof, D., Masetti, R., Anderson, B. O. and on behalf of the Breast Health Global Initiative Treatment Panel (2008), Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation. Cancer, 113: 2269–2281. doi: 10.1002/cncr.23843

Author Information

  1. 1

    Department of breast tumors, Cancer Institute “Ion Chiricuta” Cluj-Napoca, Romania

  2. 2

    Division of Oncology, Stanford University, Stanford, California

  3. 3

    Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

  4. 4

    National Cancer Institute-Brasil, Rua, Brazil

  5. 5

    Cerrahpasa Medical School Department of Radiation Oncology, Cerrahpasa, Istanbul University, Istanbul, Turkey

  6. 6

    Sandton Oncology Centre, Johannesburg, South Africa

  7. 7

    Department of Surgery, Catholic University of Rome, Rome, Italy

  8. 8

    Division of Public Health Sciences, University of Washington, Seattle, Washington and Fred Hutchinson Cancer Research Center, Seattle Washington

  1. ‡

    Fax: (011) 40 264-450348

  2. §

    Jose Bines receives honoraria from Astra-Zeneca and is a consultant to Astra-Zeneca and Bristol-Meyers-Squibb.

  3. The BHGI Treatment Panel members included Baffour Awuah, Zeba Aziz, Rajendra Badwe, José Bines, Ashwini Budrukkar, Co-chair Robert W. Carlson, Nagi S. El Saghir, Co-chair Alexandru Eniu, Nagi Khouri, Richard R. Love, Riccardo Masetti, A. Nandakumar, Twalib Ngoma, Carlos Perez, Jose Miquel Reyes, Paula Trahan Rieger, Eeva Salminen, Rama Sivaram, Tomoo Tajima, Daniel Vorobiof, Oncology, and Jo Anne Zujewski.

*Cancer Institute “I. Chiricuta”, Department of Breast Tumors, Republicii 34-36, 400015 Cluj-Napoca, Romania

  1. †

    Complete financial disclosures are presented at the end of this article.

Publication History

  1. Issue published online: 3 OCT 2008
  2. Article first published online: 3 OCT 2008
  3. Manuscript Accepted: 24 JUN 2008
  4. Manuscript Received: 10 JUN 2008

Funded by

  • The Breast Health Global Initiative (BHGI) Global Summit
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Ethicon Endo Surgery, Inc.
  • GE Healthcare
  • F. Hoffmann-La Roche AG
  • Novartis Oncology
  • Pfizer Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1033K)

REFERENCES

  • 1
    Carlson RW,Anderson BO,Burstein HJ, et al. Invasive breast cancer. J Natl Compr Canc Netw. 2007; 5: 246–312.
  • 2
    Goldhirsch A,Wood WC,Gelber RD,Coates AS,Thurlimann B,Senn HJ. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007; 18: 1133–1144.
  • 3
    Pavlidis N,Hansen H,Stahel R. ESMO clinical recommendations: a practical guide for medical oncologists. Ann Oncol. 2007; 18: 1759–1763.
  • 4
    Carlson RW,Anderson BO,Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S67–S74.
    Direct Link:
  • 5
    Eniu A,Carlson RW,Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006; 12( suppl 1): S38–S53.
    Direct Link:
  • 6
    Anderson BO,Braun S,Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003; 9( suppl 2): S42–S50.
    Direct Link:
  • 7
    Smith RA,Caleffi M,Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006; 12( suppl 1): S16–S26.
    Direct Link:
  • 8
    Shyyan R,Masood S,Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006; 12( suppl 1): S27–S37.
    Direct Link:
  • 9
    Anderson BO,Yip CH,Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006; 12( suppl 1): S54–S69.
    Direct Link:
  • 10
    Anderson BO,Shyyan R,Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006; 12( suppl 1): S3–S15.
    Direct Link:
  • 11
    Malin JL,Schneider EC,Epstein AM,Adams J,Emanuel EJ,Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006; 24: 626–634.
  • 12
    El Saghir NS,Eniu A,Carlson RW, et al.; for the Breast Health Global Initiative (BHGI) Systemic Therapy Focus Group. Management of locally advanced breast cancer: balancing clinical progress and resources. Cancer. 2008; 113 ( 8 suppl): 2315–2324.
    Direct Link:
  • 13
    Bese NS,Budrukkar A,Elzawawy A, et al.; for the Breast Health Global Initiative (BHGI) Radiation Therapy Focus Group. Breast cancer in limited resource countries: implementation and evidence-based recommendations for radiation therapy. Cancer. 2008; 113( 8 suppl): 2305–2314.
    Direct Link:
  • 14
    Clarke M,Collins R,Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087–2106.
  • 15
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687–1717.
  • 16
    Singletary SE,Allred C,Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002; 20: 3628–3636.
  • 17
    Schwartsmann G. Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol. 2001; 19( 18 suppl): 118S–124S.
  • 18
    Vorobiof DA,Sitas F,Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001; 19( 18 suppl): 125S–127S.
  • 19
    El Saghir NS,Khalil MK,Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007; 5: 225–233.
  • 20
    Rugo HS. The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors. Ann Oncol. 2008; 19: 16–27.
  • 21
    World Health Organization. Executive Summary of the National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva, Switzerland: World Health Organization; 2002.
View Full Article (HTML) Get PDF (1033K)